MCP: Study shows long-term effects of weight loss on the proteome
As hard as weight loss is, long-term maintenance can be even more of a challenge. But research published in the journal Molecular & Cellular Proteomics indicates that the hard work of maintaining weight loss can pay previously unknown health dividends.
Proteomics researchers found that many plasma proteins, such as myoglobin, shown at left, increase in nonenzymatic glycation after patients lose weight. It takes six months to a year of sustained weight loss for glycation to drop below baseline levels. PDB / S.E. Phillips
Using plasma samples from a study that followed people as they lost weight and worked to keep it off, researchers at a Swiss proteomics company called Biognosys, in collaboration with a team at Nestlé, studied how weight loss affected participants’ blood proteome. They observed that while chronic inflammation subsides immediately after weight loss, it takes some time for added beneficial effects to kick in.
The diet, obesity and genetics study, or DiOGenes for short, was designed to test the benefit of various diets in maintaining weight loss. Among the 550 participants who lost 8 percent or more of their starting weight and stayed in the study for another six months, researchers reported in 2010, those who followed a high-protein, low-glycemic-index diet were most successful at keeping it off.
More recently, researchers at Biognosys led by Lukas Reiter used a streamlined proteomics approach to analyze patient plasma samples from the start of the study, the end of its eight-week weight-loss phase, and six and 12 months into the maintenance phase. Consistent with other weight-loss studies, the team saw a dramatic, lasting drop in inflammatory signaling linked to atherosclerosis and an increase in lipid metabolism soon after weight loss.
Because of the depth of their proteome coverage, the Biognosys researchers could add a look at protein glycation. Nonenzymatic glycation occurs when high concentrations of sugar react with proteins in the plasma. Many of the glycated proteins that changed significantly during weight loss, including albumin, myoglobin and some apolipoproteins, were unexpectedly more abundant after the study’s initial weight-loss phase. It took more than six months on the weight-maintenance diet for those glycated proteins to drop back below their baseline levels. Because glycated proteins can activate the immune system, the researchers wrote, the effect of longer-term weight loss is positive.
In future studies, the researchers who own the data hope to move from looking at the whole cohort’s proteome to correlating each study participant’s outcomes with the composition of that individual’s proteome at baseline in search of biomarkers that could help predict how future dieters will fare. Meanwhile, the Biognosys team wants to use its analytic abilities to power high-throughput proteomics for clinical trials.
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.
Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.
The pipetting robots are already in place, but that doesn’t make it easy. Here's how academic laboratories are quickly pivoting to provide testing for the coronavirus.